会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Hematology linearity control composition, system and method of use
    • 血液学线性控制组成,系统和使用方法
    • US07754487B2
    • 2010-07-13
    • US11938853
    • 2007-11-13
    • Nery OrtizTheodore J. Gerula
    • Nery OrtizTheodore J. Gerula
    • G01N33/48
    • G01N33/96G01N15/12G01N2015/1006G01N2496/10Y10T436/10Y10T436/101666
    • A linearity control system includes a series of linearity control compositions, each thereof includes white blood cell analogs and stabilized red blood cells in a suspension medium. The concentration of the white blood cell analogs in the series of control compositions increases from 0.2×103 to 800×103 analogs per microliter, and the concentration of the white blood cell analogs in at least one control composition is greater than 120×103 analogs per microliter. The stabilized red blood cells facilitate mono-dispersion of the white blood cell analogs in the suspension medium by gently mixing. The control compositions further include platelet analogs, or additionally include reticulocyte and/or nucleated red blood cell analogs. The linearity control system allows the verification of the reportable measurement range and linearity of the measurements of hematology analyzers for white blood cells, red blood cells and platelets in extended concentration ranges.
    • 线性控制系统包括一系列线性控制组合物,其中每一个包括悬浮介质中的白细胞类似物和稳定的红细胞。 一系列对照组合物中白细胞类似物的浓度从0.2×103增加到800×103类似物/微升,并且至少一种对照组合物中白细胞类似物的浓度大于每个对照组合物的120×103个类似物 微升。 稳定的红细胞促进白细胞类似物在悬浮介质中的单分散,通过轻轻混合。 对照组合物还包括血小板类似物,或另外包括网织红细胞和/或有核红细胞类似物。 线性控制系统允许验证可扩展浓度范围内白细胞,红细胞和血小板的血液分析仪的可报告测量范围和线性度。
    • 10. 发明申请
    • Hematology Linearity Control Composition, System and Method of Use
    • 血液学线性控制组成,系统和使用方法
    • US20080113438A1
    • 2008-05-15
    • US11938853
    • 2007-11-13
    • Nery OrtizTheodore J. Gerula
    • Nery OrtizTheodore J. Gerula
    • G01N33/48G01N37/00
    • G01N33/96G01N15/12G01N2015/1006G01N2496/10Y10T436/10Y10T436/101666
    • A linearity control system includes a series of linearity control compositions, each thereof includes white blood cell analogs and stabilized red blood cells in a suspension medium. The concentration of the white blood cell analogs in the series of control compositions increases from 0.2×103 to 800×103 analogs per microliter, and the concentration of the white blood cell analogs in at least one control composition is greater than 120×103 analogs per microliter. The stabilized red blood cells facilitate mono-dispersion of the white blood cell analogs in the suspension medium by gently mixing. The control compositions further include platelet analogs, or additionally include reticulocyte and/or nucleated red blood cell analogs. The linearity control system allows the verification of the reportable measurement range and linearity of the measurements of hematology analyzers for white blood cells, red blood cells and platelets in extended concentration ranges.
    • 线性控制系统包括一系列线性控制组合物,其中每一个包括悬浮介质中的白细胞类似物和稳定的红细胞。 一系列对照组合物中白细胞类似物的浓度从每微升升至0.2×10 3至800×10 3个类似物,并且白细胞类似物的浓度在 至少一种对照组合物每微升大于120×10 3个类似物。 稳定的红细胞促进白细胞类似物在悬浮介质中的单分散,通过轻轻混合。 对照组合物还包括血小板类似物,或另外包括网织红细胞和/或有核红细胞类似物。 线性控制系统允许验证可扩展浓度范围内白细胞,红细胞和血小板的血液分析仪的可报告测量范围和线性度。